Cargando…
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
Understanding the mechanisms and impact of booster vaccinations are essential in the design and delivery of vaccination programs. Here we show that a three dose regimen of a synthetic peptide vaccine elicits an accruing CD8(+) T cell response against one SARS-CoV-2 Spike epitope. We see protection a...
Autores principales: | Pardieck, Iris N., van der Sluis, Tetje C., van der Gracht, Esmé T. I., Veerkamp, Dominique M. B., Behr, Felix M., van Duikeren, Suzanne, Beyrend, Guillaume, Rip, Jasper, Nadafi, Reza, Beyranvand Nejad, Elham, Mülling, Nils, Brasem, Dena J., Camps, Marcel G. M., Myeni, Sebenzile K., Bredenbeek, Peter J., Kikkert, Marjolein, Kim, Yeonsu, Cicin-Sain, Luka, Abdelaal, Tamim, van Gisbergen, Klaas P. J. M., Franken, Kees L. M. C., Drijfhout, Jan Wouter, Melief, Cornelis J. M., Zondag, Gerben C. M., Ossendorp, Ferry, Arens, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267705/ https://www.ncbi.nlm.nih.gov/pubmed/35803932 http://dx.doi.org/10.1038/s41467-022-31721-6 |
Ejemplares similares
-
Dominant Antiviral CD8(+) T Cell Responses Empower Prophylactic Antibody-Eliciting Vaccines Against Cytomegalovirus
por: Pardieck, Iris N., et al.
Publicado: (2022) -
Memory CD8(+) T cell heterogeneity is primarily driven by pathogen-specific cues and additionally shaped by the tissue environment
por: van der Gracht, Esmé T.I., et al.
Publicado: (2020) -
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors
por: Beyrend, Guillaume, et al.
Publicado: (2019) -
Delayed vaccine-induced CD8(+) T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication
por: van der Sluis, Tetje C, et al.
Publicado: (2023) -
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses
por: Oreshkova, Nadia, et al.
Publicado: (2021)